This specification relates to capsules for preparing consumable products using capsule machines, and in particular to capsules adapted to provide improved conditions for preparing a steeped consumable product in a capsule machine.
The following background discussion is not an admission that anything discussed below is citable as prior art or common general knowledge. The documents listed below are incorporated herein in their entirety by this reference to them.
Single serve capsules adapted for use in machines to prepare a desired consumable product are becoming increasingly popular. Such capsules come in a variety of formats for producing consumable products such as coffee, tea or hot chocolate.
In North America, a leading provider of capsules and capsule machines is Keurig Green Mountain Inc. This company produces K-Cup™ capsules and Keurig™ capsule machines also known as brewers). K-Cup™ capsules have a first chamber defined by a paper filter that is loosely packed with ingredients (such as ground coffee) and a second chamber downstream of the first chamber that defines an empty space for receiving a prepared product that flows through the paper filter prior to dispensing into a cup.
A predetermined volume of heated water is injected by a Keurig™ machine into the first chamber of a K-cup™ coffee capsule at a predetermined flow rate. The heated water flows through the ingredients in the capsule and contacts the paper filter. The bottom portion of the paper filter quickly becomes saturated and allows the prepared product to flow through the filter at substantially the same flow rate as fluid enters the capsule. As a result, the fluid tends to continuously flow through the ingredients with less than optimum mixing and extraction. It has been found that ingredients in K-cup™ capsules used in Keurig™ machines are not optimally saturated other than ingredients disposed along the central fluid flow path of the capsule. Nonetheless, K-cup™ capsules remain a leading brand of capsules in the North American single serve coffee market.
The optimum conditions for preparing drip-style coffee differ from the optimum conditions for preparing other forms of consumable products. For example, certain consumable products, such as whole leaf tea products, benefit from soaking or steeping (the term steeping will be used hereafter) the precursor ingredients in a fluid, such as heated water, for a desired period of time prior to dispensing into a user's cup. Such products often also benefit from a mixing or turbulence of the precursor ingredients within the fluid during the steeping phase.
A problem with conventional capsules and capsule machines such as the K-cup™ capsules and Keurig™ machines is that their structure and operations are designed primarily for the purpose of preparing drip-style filtered coffee. This problem is exasperated by the desire to produce a prepared beverage in a relatively short time frame (60 seconds or less) thus requiring fluid to be injected into the machine at a relatively high flow rate.
This problem could be addressed by designing capsule machines that provide optimum conditions for preparing a steeped consumable product. This does not provide a solution for consumers who desire a shorter preparation time or who already own a conventional capsule machine and wish to avoid acquiring a new appliance however.
There is a need for a capsule that is adapted to provide improved conditions for preparing a steeped consumable product. There is also a need for such a capsule to be used with conventional capsule machines.
In one aspect the invention provides a capsule, for use in a machine for preparing consumable products from capsules, said machine having an injection system that includes at least one injection nozzle for injecting heated fluid into said capsule at a predetermined flow rate, said capsule comprising:
a body defining an interior space with an opening;
a cover disposed over said opening, said cover being formed of a material that is resistant to tearing and adapted to shrink sufficiently around said at least one injection nozzle when said at least one injection nozzle pierces said cover and injects heated fluid into said capsule to create a seal that allows pressure to build within said interior space beneath said cover up to a maximum pressure;
a filter disposed in said interior space to define a steeping chamber between said filter and said cover, said filter being formed of one or more materials that are sufficiently phobic to said heated fluid to cause said steeping chamber to fill with fluid without exceeding said maximum pressure; and
ingredients disposed in said interior space for preparing a desired product.
In another aspect, the invention provides a capsule, for use in a machine for preparing consumable products from capsules, said capsule comprising:
a body defining an interior space with an opening;
a cover disposed over said opening;
a filter disposed in said interior space to define a chamber between said filter and said cover; and
ingredients disposed in said chamber for preparing a desired product, at least 50% of said ingredients having a particulate size greater than a #16 mesh.
Other aspects and features of the teachings disclosed herein will become apparent, to those ordinarily skilled in the art, upon review of the following description of the specific examples of the specification.
The drawings included herewith are for illustrating various examples of articles, methods, and apparatuses of the present specification and are not intended to limit the scope of what is taught in any way. For simplicity and clarity of illustration, where considered appropriate, reference numerals may be repeated among the drawings to indicate corresponding or analogous elements.
Various apparatuses or methods will be described below to provide examples of the claimed invention. The claimed invention is not limited to apparatuses or methods having all of the features of any one apparatus or method described below or to features common to multiple or all of the apparatuses described below. The claimed invention may reside in a combination or sub-combination of the apparatus elements or method steps described below. It is possible that an apparatus or method described below is not an example of the claimed invention. The applicant(s), inventor(s) and/or owner(s) reserve all rights in any invention disclosed in an apparatus or method described below that is not claimed in this document and do not abandon, disclaim or dedicate to the public any such invention by its disclosure in this document.
A capsule in accordance with the present invention is shown generally at 10 in the Figures. Capsule 10 includes a body 12, filter 14, ingredients 16 and cover 18. Body 12 and cover 18 are each preferably formed of multilayered materials that include one or more barrier layers providing barriers against one or more environmental factors such as light, oxygen, and moisture. Capsule 10 may be sized to provide a single serving of a desired product or multiple servings.
Capsule 10 is sized and configured for use in a machine 20 that is adapted for preparing a product from capsule 10.
Machine 20 includes an injection system 22 for injecting a fluid, typically heated water, into the capsule 10 for mixing with ingredients 16. Injection system 22 may include at least one injection nozzle 22a disposed on machine 20 that is adapted to pierce cover 18 to inject fluid into capsule 10. In an alternative embodiment (not shown), injection system 22 may have at least one component disposed on capsule 10, such as on body 12 beneath cover 18, and adapted to pierce cover 18 and interact with other components of injection system 22 on machine 20 to inject fluid into capsule 10.
Machine also includes a dispensing system 24 for dispensing product from capsule 10 into a desired receptacle such as a bowl or cup. Dispensing system 24 may include a hollow probe 24a that is adapted to pierce capsule 10 to dispense a prepared product from capsule 10.
Body 12 of capsule 10 includes a sidewall 30 and an end wall 32 together defining an interior space 34. Interior space 34 preferably has a volume in the range of 30 cc to 100 cc for preparing a single serving of beverage and more preferably a volume in the range of 40 cc to 80 cc.
An opening 36 is defined at one end of body 12 and a flange 38 extends around the perimeter of opening 36 to receive cover 18 and to support capsule 10 within machine 20. Filter 14 may be secured to flange 38 or to an interior surface of capsule 10 (such as to sidewall 30 or the underside of cover 18).
In another embodiment (not shown), body 12 may be formed with no end wall 32 and no sidewall 30 or a partial sidewall 30. Flange 38 may still extend around the perimeter of opening 36 to receive cover 18 and to support capsule 10 within machine 20. Filter 14 may be secured to flange 38 or to partial sidewall 30 or underside of cover 18.
Cover 18 is disposed over opening 36 and secured to body 12 such as by sealing cover 18 directly to flange 38 or by sealing cover 18 to filter 14 which in turn is sealed to flange 38. Cover 18 may be transparent in order that ingredients 16 may be viewed through cover 18 prior to use of capsule 10 in machine 20.
Cover 18 is formed of a material that is resistant to tearing and adapted to shrink upon exposure to heat. Cover 18 is thus adapted to shrink around the opening formed in cover 18 by injection system 22 to form a sufficient seal to withstand the buildup in pressure within capsule 10 under normal conditions during use in machine 20. In other words, cover 18 is adapted to shrink sufficiently around the at least one injection nozzle when the at least one injection nozzle pierces the cover and injects heated fluid into the capsule to create a seal and allow the buildup in pressure within capsule up to a maximum pressure.
Preferably, cover 18 is formed of a multi-layered material having a minimum tensile strength of 3000 psi and a minimum elongation of 50%. Preferably cover 18 includes polymer materials, more preferably cover 18 comprises at least 50% polymer materials and most preferably cover 18 comprises at least 75% polymer materials.
Examples of suitable materials for cover 18 include polyethylene (PE), polyethylene terephthalate (PET) and polyamide PA6. A multi-layered material for cover 18 may include at least one layer formed of a continuous film of tear resistant and heat shrinkable material (laminated or extrusion coated) or a non-continuous film such as a non-woven polymer, mesh or perforated film. Examples of a multi-layered material for cover 18 include (from outside layer to inside layer): PET/aluminum foil/PE, PET/EVOH/PE, PET/metalized PET/PE or PET/PE. It has been found that formation of cover 18 from a multilayered PET/PE or PET/EVOH/PE material comprising at least 90% polymer materials provides preferred sealing performance around injection system 22.
A steeping chamber 40 is defined within interior space 34 of capsule 10 between cover 18 and filter 14. Steeping chamber 40 has a volume V1 that is adapted to contain a sufficient volume V2 of ingredients 16 to produce a desired consumable product using machine 20. Ingredients 16 that are disposed in steeping chamber 40, as described further below, are preferably selected for optimum extraction under the conditions within steeping chamber 40 during use of machine 20.
For the embodiment depicted in
Filter 14 has an average fluid flow rate F1 that is less than the average fluid flow rate F2 of injection system 22. Preferably, the average fluid flow rate F1 of filter 14 is between 50% and 90% of the average fluid flow rate F2 of injection system 22, more preferably between 55% and 80% and most preferably between 60% and 75%.
The average fluid flow rates F1 and F2 noted above are determined over the course of the product preparation process using machine 20 in accordance with the test procedure below. An empty capsule 10 containing no filter 14 and no ingredients 16 is disposed in machine 20 and machine 20 is activated to prepare a product of a selected size. The weight of the product prepared by the machine 20 is measured as well as the time required to prepare the product from the moment machine 20 is activated to the moment the flow of prepared product has stopped. The measured weight per unit of time is deemed to be the fluid flow rate F2 for injection system 22. The first capsule is removed and an empty capsule 10 with a filter 14 (but no ingredients 16) is then disposed in same machine 20 and machine 20 is activated to prepare a product of the same selected size. The weight of the product prepared by machine 20 is measured as well as the time required to prepare the product from the moment machine 20 is activated to the moment the flow of prepared product has stopped. The measured weight per unit of time is deemed to be the fluid flow rate F1 for filter 14.
Filter 14 may have a uniform fluid flow rate F1 over its entire surface area within interior space 34 or it may be adapted to provide zones 42 having different rates of fluid flow. Filter 14 may thus be adapted to provide one or more high flow zones 42a that allow a relatively higher rate of fluid flow as compared to the remainder of filter 14. Conversely, filter 14 may be adapted to provide one or more low flow zones 42b that allow a relatively low rate of fluid flow as compared to the remainder of filter 14. Zones 42 may also be disposed at desired locations L on filter 14 to optimize the performance of steeping chamber 40. For example, high flow zones 42a may be at locations L1 on filter 14 proximate to cover 18 to allow air to flow in the head space above the fluid to balance the pressure differential between steeping chamber 40 and the remainder of capsule 10. Low flow zones 42b may be at locations L2 along the sides of filter 14 to reduce the fluid flow along such side portions and thus encourage flow through the bottom portion of filter 14.
Filter 14 is also adapted to be phobic to the fluid being injected into capsule 10. In most instances, the fluid will comprise water (either heated or cooled) and a hydrophobic filter 14 is desired. Filter 14 may be formed of materials that are phobic to fluid such as polyolefins (eg, polyethylene, polypropylene) and mixtures of polyolefins with other polymers or filter 14 may be coated with materials that are phobic to fluid such as a polyethylene coating.
Filter 14 preferably has an air permeability of at least 400 L/s.m2, more preferably at least 1000 L/s.m2 and even more preferably at least 1800 L/s.m2 (all measurements based on ASTM Standard D737-96 “Standard Test Method for Air Permeability of Textile Fabrics”). By comparison, the conventional pleated paper filter for the Keurig K-cup™ capsule has a basis weight of 40 grams per square meter (gsm) and an air permeability of approximately 250 L/s. m2.
Preferably, filter 14 is formed of a non-woven fabric filtration material such as polyester, polyethylene or nylon non-woven fabric. The basis weight for filter 14 is in the range of 40 to 150 gsm and more preferably between 70 to 120 gsm.
Preferably, filter 14 is formed of a moldable non-woven filtration material that includes a plurality of multi-component fibers that are bound or interlocked by non-woven manufacturing techniques (such as spun bond techniques) to form a web having channels extending from one side of filter 14 to the other. The desired diameter for channels after forming is between 20 and 100 μm, more preferably between 40 to 80 μm. More details of a preferred filtration material for filter 14 are provided in co-pending patent application Ser. No. 14/074,024 which is incorporated in its entirety herein by reference.
Filter 14 may alternatively be formed of a polymer sheet, such as polyester or Nylon, which may be perforated or otherwise modified to define channels. The size and distribution of openings are optimized in a way that is resistant to water exiting.
Filter 14 may alternatively be formed from an ultra high molecular weight polyethylene (UHWMPE) which is also a filter material due to the cavities/pores formed during polymerization.
Filter 14 may alternatively be formed from modified filter paper with a phobic coating to achieve the fluid resistant property. Preferably, the coating is distributed on filter in a manner that creates high flow zones and/or low flow zones as described further below.
More details of the manner for securing filter 14 and cover 18 to flange 38 of body 12 are provided in co-pending patent application Ser. No. 13/600,582 which is incorporated in its entirety herein by reference.
Cover 18 and filter 14 may be adapted to be removed from body 12 for instance by separating an integral tab (not shown) defined in flange 38 and applying a peeling force. More details of capsules 10 having portions that are removable are provided in co-pending patent application Ser. No. 14/098,915 which is incorporated in its entirety herein by reference.
While filter 14 has an average fluid flow rate F1 over the course of the product preparation process in machine 20, the fluid flow rate may vary widely at different times during the process due to the fluid phobic properties of filter 14. At the beginning of the product preparation process for example, as steeping chamber 40 is filling with fluid, the phobic properties of filter 14 may result in little or no fluid flowing through filter 14. This results in an extended dwell time for ingredients 16 and fluid within steeping chamber 40. Once steeping chamber 40 is filled with fluid then the fluid flow rate of filter 14 may increase as fluid continues to flow into steeping chamber 40 through injection system 22 and as the surface tension of fluid is broken and fluid is forced to flow through filter 14. Certain machines 20 may further include a pulse cycle that varies the timing and/or amount of fluid that is injected into the capsule 10 using injection system 22.
The phobic properties of filter 14 are adapted to restrict the flow of fluid through capsule 10 by a sufficient amount within the operational constraints of machine 20 to optimize the extraction or infusion of ingredients 16 disposed within steeping chamber 40. As described further below, once steeping chamber 40 is filled with fluid, the pressure within steeping chamber 40 will increase as the fluid continues to flow into steeping chamber 40 through injection system 22. The increase in pressure within steeping chamber 40 is believed to further enhance the process of extraction or infusion of ingredients 16 disposed within steeping chamber 40. Also, extracts from ingredients 16 such as aroma and taste compounds, lipid and functional compounds may act to reduce the surface tension of fluid to further permit flow through filter 14.
A steeping chamber 40 having a greater volume V1 will take a greater period of time in a machine 20 to fill with fluid before pressure builds up within steeping chamber 40. A steeping chamber 40 having a lesser volume V1 will conversely take a lesser period of time to fill with fluid and thus will build up pressure sooner and to a greater extent as fluid continues to flow into steeping chamber 40. It has been found that a lesser volume V1 is preferred for optimum performance of steeping chamber 40.
Ingredients 16 that are disposed in steeping chamber 40 may include insoluble ingredients 16 such as tea leaves, coffee grounds, herbs, spices or other ingredients adapted for forming a consumable product by extraction or infusion. Additional ingredients 16 may be disposed either in steeping chamber 40 or elsewhere in interior space 34. Such additional ingredients 16 may include soluble ingredients 16 such as coffee, chocolate, soup stock, flavor additives or other ingredients in powdered, crystallized or other forms adapted for solubility or contained within a soluble film or pouch. Additional ingredients 16 may also include active ingredients (eg foaming agents), natural health additives, regulated drugs, alcohol or other soluble or insoluble ingredients.
One or more ingredients 16 may include sensory attributes that are desirable to convey to a consumer or end user prior to the preparation of the consumable product. For example, ingredients 16 may include soluble or insoluble ingredients having visual attributes that may be of interest to a consumer. Examples of ingredients 16 with visual attributes include whole tea leaves, florets, pieces of dried fruit, vegetables, herbs, nuts or beans, pieces of chocolate, spices (such as cloves or cinnamon sticks), natural health additives (eg gogi berries), dried pieces of meat (eg shrimp), tofu, vegetables or noodles for soup.
In a preferred embodiment, ingredients 16 include a subset of ingredients having irregular shapes and/or relatively large particulate sizes such as one or more of whole leaf teas, herbs, spices, fruits and flowers. Preferably ingredients 16 include a combination of larger particulate sizes and smaller particulate sizes. Ingredients having larger particulate sizes may include whole or substantially whole leaves or other desired portions of tea, herbs, spices, fruits and flowers. Ingredients having smaller particulate sizes may include cut, ground, crystallized or otherwise processed portions of such ingredients. Preferably, at least 50% of the ingredients comprise ingredients having a particulate size greater than a #16 mesh (1.18 mm). More preferably, at least 70% of the ingredients comprise ingredients having a particulate size greater than a #16 mesh.
In one embodiment, for single serve capsules 10 having a volume up to 100 cc, a preferred consumable product having improved sensory attributes is formed from 1.5 grams to 30 grams of ingredients 16 comprising one or more of whole leaf teas, herbs, spices, fruits or flowers as described above in which at least 50% of ingredients 16 have a particle size of at least 1.18 mm (mesh #16).
In other embodiments, multiple filters 14 may be disposed within interior space 34 of capsule 10. Such filters 14 may be disposed inside or outside of steeping chamber 40. Additional filters 14 may have different average fluid flow rates as well as different degrees of phobicity or non-phobicity to fluid.
Capsule 10 includes a steeping chamber 40 defined between cover 18 and filter 14a. Filter 14a has fluid phobic properties similar to those described in the embodiment above. It may be seen that steeping chamber 40 has a greater volume V1 than the volume V1 for the embodiment of capsule 10 described above. This allows a longer dwell time before the conditions within steeping chamber 40 cause fluid to flow through filter 14a.
Capsule 10 further includes a second filter 14b disposed in steeping chamber 40 above filter 14a. Second filter 14b defines a first ingredients chamber 44 that is disposed proximate to a transparent cover 18. Ingredients chamber 44 is adapted to contain a subset of ingredients 16a that have visual attributes that may be viewed through transparent cover 18. Additional ingredients 16b are disposed in steeping chamber 40 outside of first ingredients chamber 44 (these may include additional insoluble ingredients 16 that may have less desirable visual attributes). Additional ingredients 16c may also be disposed in interior space 34 outside of steeping chamber 40 (these may include soluble or active ingredients 16).
Referring to
While the above description provides examples of one or more processes or apparatuses, it will be appreciated that other processes or apparatuses may be within the scope of the accompanying claims.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/CA2015/050214 | 3/20/2015 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2015/139140 | 9/24/2015 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2113715 | Wilcox | Apr 1938 | A |
2987221 | Milton | Jun 1961 | A |
3110121 | Corrinet | Nov 1963 | A |
3282703 | Broadhurst | Nov 1966 | A |
3399806 | Lucas | Sep 1968 | A |
3713936 | Ramsay | Jan 1973 | A |
4101627 | Menier | Jul 1978 | A |
4131064 | Ryan et al. | Dec 1978 | A |
4220673 | Strobel | Sep 1980 | A |
4235160 | Olney et al. | Nov 1980 | A |
4306367 | Otto | Dec 1981 | A |
4440796 | Lunder et al. | Apr 1984 | A |
4471689 | Piana | Sep 1984 | A |
4518639 | Phillips | May 1985 | A |
4559729 | White | Dec 1985 | A |
4619830 | Napier | Oct 1986 | A |
4701365 | Iwaski | Oct 1987 | A |
4728425 | Sandvig | Mar 1988 | A |
4859337 | Woltermann | Aug 1989 | A |
4865737 | McMichael | Sep 1989 | A |
4867993 | Nordskog | Sep 1989 | A |
4981588 | Poulallion | Jan 1991 | A |
4983410 | Dinos | Jan 1991 | A |
4995310 | van der Lijn et al. | Feb 1991 | A |
4996066 | Love et al. | Feb 1991 | A |
5008013 | Favre et al. | Apr 1991 | A |
5076433 | Howes | Dec 1991 | A |
5298267 | Gruenbacher | Mar 1994 | A |
5331793 | Pophal et al. | Jul 1994 | A |
5390587 | Wu | Feb 1995 | A |
5447631 | Mahlich | Sep 1995 | A |
5456929 | Mifune et al. | Oct 1995 | A |
5496573 | Tsuji et al. | Mar 1996 | A |
5536290 | Stark et al. | Jul 1996 | A |
5575383 | Seeley | Nov 1996 | A |
5601716 | Heinrich et al. | Feb 1997 | A |
5605710 | Prindonoff et al. | Feb 1997 | A |
5633026 | Gruenbacher | May 1997 | A |
5738786 | Winnington-Ingram | Apr 1998 | A |
5806582 | Howes | Sep 1998 | A |
5840189 | Sylvan et al. | Nov 1998 | A |
5858437 | Anson | Jan 1999 | A |
5866185 | Burkett | Feb 1999 | A |
5871096 | Yakich | Feb 1999 | A |
5871644 | Simon et al. | Feb 1999 | A |
5882716 | Munz-Schaerer et al. | Mar 1999 | A |
5885314 | Oussoren et al. | Mar 1999 | A |
5895672 | Cooper | Apr 1999 | A |
5896686 | Howes | Apr 1999 | A |
5897899 | Fond | Apr 1999 | A |
5923242 | Slagle et al. | Jul 1999 | A |
5957279 | Howes | Sep 1999 | A |
5971195 | Reidinger et al. | Oct 1999 | A |
6025000 | Fond et al. | Feb 2000 | A |
6146270 | Huard et al. | Nov 2000 | A |
6189438 | Bielfeldt et al. | Feb 2001 | B1 |
6220147 | Priley | Apr 2001 | B1 |
6223937 | Schmidt | May 2001 | B1 |
6440256 | Gordon et al. | Aug 2002 | B1 |
6514555 | Fayard et al. | Feb 2003 | B1 |
6548433 | Gbur et al. | Apr 2003 | B1 |
6557597 | Riesterer | May 2003 | B2 |
6561232 | Frutin | May 2003 | B1 |
6589577 | Lazaris et al. | Jul 2003 | B2 |
6607762 | Lazaris et al. | Aug 2003 | B2 |
6622615 | Heczko | Sep 2003 | B2 |
6644173 | Lazaris et al. | Nov 2003 | B2 |
6645537 | Sweeney et al. | Nov 2003 | B2 |
6658989 | Sweeney et al. | Dec 2003 | B2 |
6720070 | Hamaguchi et al. | Apr 2004 | B2 |
6758130 | Sargent et al. | Jul 2004 | B2 |
6810788 | Hale | Nov 2004 | B2 |
6841185 | Sargent et al. | Jan 2005 | B2 |
6854378 | Jarisch et al. | Feb 2005 | B2 |
6869627 | Perkovic et al. | Mar 2005 | B2 |
6913777 | Rebhorn et al. | Jul 2005 | B2 |
6959832 | Sawada | Nov 2005 | B1 |
6992586 | Rosenfeld | Jan 2006 | B2 |
7067038 | Trokhan et al. | Jun 2006 | B2 |
7153530 | Masek et al. | Dec 2006 | B2 |
7279188 | Arrick et al. | Oct 2007 | B2 |
7311209 | Bentz et al. | Dec 2007 | B2 |
7328651 | Halliday et al. | Feb 2008 | B2 |
7387063 | Vu et al. | Jun 2008 | B2 |
7412921 | Hu et al. | Aug 2008 | B2 |
7490542 | Macchi et al. | Feb 2009 | B2 |
7543527 | Schmed | Jun 2009 | B2 |
7552672 | Schmed | Jun 2009 | B2 |
7552673 | Levin | Jun 2009 | B2 |
7624673 | Zanetti | Jun 2009 | B2 |
7594470 | Scarchilli et al. | Sep 2009 | B2 |
7640842 | Bardazzi | Jan 2010 | B2 |
7681492 | Suggi et al. | Mar 2010 | B2 |
7685930 | Mandralis et al. | Mar 2010 | B2 |
7763300 | Sargent et al. | Jul 2010 | B2 |
7798055 | Mandralis et al. | Sep 2010 | B2 |
7854192 | Denisart et al. | Dec 2010 | B2 |
7856920 | Schmed et al. | Dec 2010 | B2 |
7856921 | Arrick et al. | Dec 2010 | B2 |
7910145 | Reati | Mar 2011 | B2 |
8062682 | Mandralis et al. | Nov 2011 | B2 |
8225771 | Andre | Jul 2012 | B2 |
8286547 | Lassota | Oct 2012 | B1 |
8361527 | Winkler et al. | Jan 2013 | B2 |
8409646 | Yoakim et al. | Apr 2013 | B2 |
8425957 | Steenhof | Apr 2013 | B2 |
8474368 | Kilber et al. | Jul 2013 | B2 |
8475854 | Skalski et al. | Jul 2013 | B2 |
8481097 | Skalski et al. | Jul 2013 | B2 |
8573114 | Huang et al. | Nov 2013 | B2 |
8591978 | Skalski et al. | Nov 2013 | B2 |
8673379 | Skalski et al. | Mar 2014 | B2 |
8740020 | Marina et al. | Jun 2014 | B2 |
8834948 | Estabrook et al. | Sep 2014 | B2 |
20020020659 | Sweeney et al. | Feb 2002 | A1 |
20030005826 | Sargent et al. | Jan 2003 | A1 |
20030039731 | Dalton et al. | Feb 2003 | A1 |
20030082360 | O'Donnell et al. | May 2003 | A1 |
20030087005 | Baron | May 2003 | A1 |
20040045443 | Lazaris | Mar 2004 | A1 |
20050016383 | Kirschner et al. | Jan 2005 | A1 |
20050051478 | Karanikos et al. | Mar 2005 | A1 |
20050287251 | Lazaris et al. | Dec 2005 | A1 |
20060057373 | Inagaki et al. | Mar 2006 | A1 |
20060236871 | Ternite et al. | Oct 2006 | A1 |
20060246187 | Egolf et al. | Nov 2006 | A1 |
20070144356 | Rivera | Jun 2007 | A1 |
20070148290 | Ternite | Jun 2007 | A1 |
20070275125 | Catani | Nov 2007 | A1 |
20080015098 | Littlejohn et al. | Jan 2008 | A1 |
20080142115 | Vogt et al. | Jun 2008 | A1 |
20080156196 | Doglioni et al. | Jul 2008 | A1 |
20080202075 | Kronawittleithner et al. | Aug 2008 | A1 |
20080245236 | Ternite et al. | Oct 2008 | A1 |
20090110775 | Rijskamp et al. | Apr 2009 | A1 |
20090133584 | De Graaff et al. | May 2009 | A1 |
20090165228 | Kilkenny | Jul 2009 | A1 |
20090175986 | Doglioni Majer | Jul 2009 | A1 |
20090186141 | Almblad et al. | Jul 2009 | A1 |
20090206084 | Woolf et al. | Aug 2009 | A1 |
20090211458 | Denisart et al. | Aug 2009 | A1 |
20090260690 | Bell | Oct 2009 | A1 |
20090311389 | Zoss et al. | Dec 2009 | A1 |
20090324791 | Ohresser et al. | Dec 2009 | A1 |
20100003379 | Zoss et al. | Jan 2010 | A1 |
20100028495 | Novak et al. | Feb 2010 | A1 |
20100116772 | Teys | May 2010 | A1 |
20100215808 | Versini | Aug 2010 | A1 |
20100239733 | Yoakim et al. | Sep 2010 | A1 |
20100303964 | Beaulieu et al. | Dec 2010 | A1 |
20110003040 | Graf et al. | Jan 2011 | A1 |
20110033580 | Bieshuevel et al. | Feb 2011 | A1 |
20110045144 | Boussemart et al. | Feb 2011 | A1 |
20110076361 | Peterson et al. | Mar 2011 | A1 |
20110183048 | Noble et al. | Jul 2011 | A1 |
20110185911 | Rapparini | Aug 2011 | A1 |
20110247975 | Rapparini | Oct 2011 | A1 |
20120006205 | Vanni | Jan 2012 | A1 |
20120024160 | Van et al. | Feb 2012 | A1 |
20120052163 | Doleac et al. | Mar 2012 | A1 |
20120058226 | Winkler et al. | Mar 2012 | A1 |
20120070542 | Camera et al. | Mar 2012 | A1 |
20120070551 | Mahlich | Mar 2012 | A1 |
20120097602 | Tedford | Apr 2012 | A1 |
20120121764 | Lai et al. | May 2012 | A1 |
20120171334 | Yoakim | Jul 2012 | A1 |
20120174794 | Fraij | Jul 2012 | A1 |
20120180670 | Yoakim | Jul 2012 | A1 |
20120180671 | Baudet | Jul 2012 | A1 |
20120183649 | Burkhalter | Jul 2012 | A1 |
20120186457 | Ozanne | Jul 2012 | A1 |
20120196008 | York | Aug 2012 | A1 |
20120199007 | Larzul | Aug 2012 | A1 |
20120199010 | Mariller | Aug 2012 | A1 |
20120199011 | Cheng | Aug 2012 | A1 |
20120201933 | Dran et al. | Aug 2012 | A1 |
20120207893 | Kreuger | Aug 2012 | A1 |
20120207894 | Webster | Aug 2012 | A1 |
20120210876 | Glucksman | Aug 2012 | A1 |
20120210878 | Mariller | Aug 2012 | A1 |
20120210879 | Mariller | Aug 2012 | A1 |
20120231123 | Kamerbeek | Sep 2012 | A1 |
20120231124 | Kamerbeek | Sep 2012 | A1 |
20120231126 | Lo Faro | Sep 2012 | A1 |
20120231133 | Kamerbeek | Sep 2012 | A1 |
20120251668 | Wong | Oct 2012 | A1 |
20120251669 | Kamerbeek | Oct 2012 | A1 |
20120251670 | Kamerbeek | Oct 2012 | A1 |
20120251671 | Kamerbeek | Oct 2012 | A1 |
20120251692 | Kamerbeek | Oct 2012 | A1 |
20120251693 | Kamerbeek | Oct 2012 | A1 |
20120251694 | Kamerbeek | Oct 2012 | A1 |
20120258204 | Tsuji | Oct 2012 | A1 |
20120258210 | Wong | Oct 2012 | A1 |
20120258219 | Wong | Oct 2012 | A1 |
20120258221 | Wong | Oct 2012 | A1 |
20120260806 | Rolfes | Oct 2012 | A1 |
20120263829 | Kamerbeek | Oct 2012 | A1 |
20120263830 | Kamerbeek | Oct 2012 | A1 |
20120263833 | Wong | Oct 2012 | A1 |
20120266755 | Baudet | Oct 2012 | A1 |
20120269933 | Rapparini | Oct 2012 | A1 |
20120272830 | Gugerli | Nov 2012 | A1 |
20120276252 | Bunke | Nov 2012 | A1 |
20120276255 | Verbeek | Nov 2012 | A1 |
20120297987 | Lee | Nov 2012 | A1 |
20120301581 | Abegglen | Nov 2012 | A1 |
20120307024 | Howes | Dec 2012 | A1 |
20120308688 | Peterson | Dec 2012 | A1 |
20120312174 | Lambert | Dec 2012 | A1 |
20120321755 | Macaulay | Dec 2012 | A1 |
20120321756 | Estabrook et al. | Dec 2012 | A1 |
20120328739 | Nocera | Dec 2012 | A1 |
20120328740 | Nocera | Dec 2012 | A1 |
20120328744 | Nocera | Dec 2012 | A1 |
20130004629 | Clark | Jan 2013 | A1 |
20130004637 | Gugerli | Jan 2013 | A1 |
20130008316 | Hoeglauer | Jan 2013 | A1 |
20130011521 | Weijers et al. | Jan 2013 | A1 |
20130017303 | Vu | Jan 2013 | A1 |
20130025466 | Fu | Jan 2013 | A1 |
20130032034 | Jarisch | Feb 2013 | A1 |
20130047863 | Larzul | Feb 2013 | A1 |
20130059039 | Trombetta | Mar 2013 | A1 |
20130059903 | Deuber | Mar 2013 | A1 |
20130068109 | Pribus et al. | Mar 2013 | A1 |
20130084368 | Linck et al. | Apr 2013 | A1 |
20130095219 | de Graaff et al. | Apr 2013 | A1 |
20130115342 | Van et al. | May 2013 | A1 |
20130122153 | Ferrier et al. | May 2013 | A1 |
20130122167 | Winkler et al. | May 2013 | A1 |
20130142931 | Fin et al. | Jun 2013 | A1 |
20130156899 | Quinn | Jun 2013 | A1 |
20130259982 | Abegglen et al. | Oct 2013 | A1 |
20130340626 | Oh | Dec 2013 | A1 |
20130344205 | Oh | Dec 2013 | A1 |
20140013958 | Krasne et al. | Jan 2014 | A1 |
20140037802 | Cardoso | Feb 2014 | A1 |
20140099388 | Wang et al. | Apr 2014 | A1 |
20140124435 | Jackson | May 2014 | A1 |
20140220192 | Deeb | Aug 2014 | A1 |
20150050391 | Rapparini | Feb 2015 | A1 |
Number | Date | Country |
---|---|---|
2012891 | Sep 1991 | CA |
2276927 | Jan 2000 | CA |
2516417 | Sep 2004 | CA |
2517840 | Nov 2004 | CA |
2689804 | Mar 2008 | CA |
2686347 | Dec 2008 | CA |
2745239 | Jun 2010 | CA |
2807489 | Feb 2012 | CA |
2824199 | Aug 2012 | CA |
2831304 | Oct 2012 | CA |
2759782 | Nov 2012 | CA |
2839293 | Dec 2012 | CA |
2810236 | Mar 2013 | CA |
0047169 | Mar 1982 | EP |
0145499 | Jun 1985 | EP |
0432126 | Jun 1991 | EP |
0 615 921 | Sep 1994 | EP |
1208782 | Aug 2004 | EP |
1593329 | Nov 2005 | EP |
1859683 | Nov 2007 | EP |
2230195 | Sep 2010 | EP |
2345351 | Jul 2011 | EP |
2409608 | Jan 2012 | EP |
2930522 | Oct 2009 | FR |
803486 | Oct 1958 | GB |
962038 | Jun 1964 | GB |
2074838 | Nov 1981 | GB |
662737 | Mar 1994 | JP |
11171249 | Jun 1999 | JP |
9212660 | Aug 1992 | WO |
0145616 | Jun 2001 | WO |
03082065 | Oct 2003 | WO |
2004083071 | Sep 2004 | WO |
2004112556 | Dec 2004 | WO |
2009114119 | Sep 2009 | WO |
2010013146 | Feb 2010 | WO |
2010066705 | Jun 2010 | WO |
2010085824 | Aug 2010 | WO |
2011095518 | Aug 2010 | WO |
201006516 | Sep 2010 | WO |
2010137956 | Dec 2010 | WO |
2012031106 | Mar 2012 | WO |
2012069505 | May 2012 | WO |
2014037339 | Mar 2014 | WO |
2014056862 | Apr 2014 | WO |
Entry |
---|
Kalpakjian, Schmid, Polymer Properties, Table 10.1, Manfacturing Processes for Engineering Materials 5th ed., Pearson Education 2008, [on line]. Downloaded from the Internet: URL:<https://www.slideshare.net/abhalim77/ch10-53447436>. |
International Search Report in PCT/CA2015/050214 dated Jun. 17, 2015. |
Number | Date | Country | |
---|---|---|---|
20180118450 A1 | May 2018 | US |
Number | Date | Country | |
---|---|---|---|
61968843 | Mar 2014 | US |